Word

LUNDBECK INSTITUTE

Status

Registered

Status Code

700

Status Date

Tuesday, August 13, 2019

Serial Number

87868893

Registration Number

5831124

Registration Date

Tuesday, August 13, 2019

Mark Type

3000

Filing Date

Monday, April 9, 2018

Published for Opposition

Tuesday, May 28, 2019

Trademark Owner History

H. Lundbeck A-S - Original Registrant

Classifications

41 Educational services, namely, conducting seminars in the field of pharmaceuticals and disease awareness; providing of training in the field of pharmaceuticals and disease awareness; arranging and conducting seminars, conferences, symposiums, training workshops and courses in the field of pharmaceuticals and disease awareness; educational training services in the fields of pharmaceutical research and development, medical clinical studies, pharmaceutical tests and trials and diagnostic medicine related to the treatment and prevention of diseases and disorders; providing the aforementioned services electronically, on-line, via cable or Internet or other electronic media; arranging and conducting expert forums, namely, on-line training programs in the field of pharmaceuticals; providing on-line, non-downloadable publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of pharmaceutical research and development, science, medical clinical studies in the field of pharmaceutical tests and trials, diagnostic medicine, pharmaceuticals, disorders, disease awareness, treatment and prevention related to the assessment of cognitive functions; providing educational assessment services in the field of cognitive functions through on-line non-downloadable screening tools

9 Downloadable electronic publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of pharmaceutical research and development, disease awareness, medical clinical studies, pharmaceutical tests and trials, diagnostic medicine, medicine, pharmaceuticals, disorders, diseases, clinical or medical treatment and prevention; software for medical and pharmaceutical information, education and sales activities, namely, software featuring audio and video information for pharmaceutical representatives on the subject of pharmaceuticals for use in the treatment of medical conditions; software for analyzing medical and pharmaceutical information and featuring information on disease symptoms for use in promoting disease awareness; software, namely, application software for mobile devices for analyzing medical and pharmaceutical information; apparatus and instruments for medical research and scientific research purposes, namely, mass spectrometers for analyzing medical and pharmaceutical information in the field of research and development, science, clinical studies, medical clinical tests and trials, pharmaceuticals, disorders and diseases; electronic downloadable publications, namely, magazines, journals, teaching and educational materials in the field of pharmaceutical research and development, science, medical clinical studies, pharmaceutical tests and trials, diagnostic medicine related to clinical or medical treatment and prevention

5 Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and chemical dependency; diagnostic agents, reagents, preparations and substances for medical purposes

16 Paper, cardboard, paper labels, printed publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of pharmaceutical research and development, science, medical clinical studies, pharmaceutical tests and trials, diagnostic medicine, medicine, pharmaceuticals, disorders, diseases, treatment and prevention

42 Pharmaceutical research and development; scientific and technological services, namely, scientific testing and research related to medical disorders, medical diseases and medical prevention; scientific and technological services, namely, scientific testing and research related to the central nervous system and central nervous system related disorders, pharmaceuticals and disease awareness; medical and clinical research, namely, pharmaceutical clinical research and conducting clinical trials for others in the field of pharmaceuticals; diagnostic research and tests in the field of pharmaceutical research

The mark consists of the words "Lundbeck Institute" in red stylized lettering beside a stylized design of a red square above a red triangular shape with curved sides and a white trapezoid at its center. The white background is not claimed as a feature of the mark.
The color(s) red and white is/are claimed as a feature of the mark.
"INSTITUTE"

Trademark Events

Mar 22, 2024

Teas Change Of Correspondence Received

Mar 22, 2024

Teas Change Of Domestic Representatives Address

Mar 22, 2024

Teas Withdrawal As Domestic Representative Received

Mar 22, 2024

Attorney/Dom.Rep.Revoked And/Or Appointed

Mar 22, 2024

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Aug 13, 2019

Registered-Principal Register

May 28, 2019

Official Gazette Publication Confirmation E-Mailed

May 28, 2019

Published For Opposition

May 8, 2019

Notification Of Notice Of Publication E-Mailed

Apr 25, 2019

Approved For Pub - Principal Register

Apr 9, 2019

Teas/Email Correspondence Entered

Apr 9, 2019

Correspondence Received In Law Office

Apr 9, 2019

Teas Response To Office Action Received

Jan 9, 2019

Notification Of Non-Final Action E-Mailed

Jan 9, 2019

Non-Final Action E-Mailed

Jan 9, 2019

Non-Final Action Written

Dec 12, 2018

Teas/Email Correspondence Entered

Dec 12, 2018

Correspondence Received In Law Office

Dec 10, 2018

Assigned To Lie

Dec 10, 2018

Assigned To Lie

Dec 5, 2018

Teas Response To Office Action Received

Jun 26, 2018

Notification Of Non-Final Action E-Mailed

Jun 26, 2018

Non-Final Action E-Mailed

Jun 26, 2018

Non-Final Action Written

Jun 21, 2018

Assigned To Examiner

Apr 19, 2018

Notice Of Design Search Code E-Mailed

Apr 18, 2018

New Application Office Supplied Data Entered

Apr 12, 2018

New Application Entered